Jobs with Karmanos Cancer Hospital & Company Information

Search for jobs at Karmanos Cancer Hospital

Karmanos Cancer Hospital Company History

Karmanos is also involved in new treatments for mesothelioma patients, including the use of Alimta® (pemetrexed), a drug that blocks the enzymes necessary for cancer cells to synthesize thymidine and purine. The Food and Drug Administration (FDA) recently approved a combination of Alimta® plus a standard chemotherapy drug, cisplatin, to treat pleural mesothelioma, the form of the disease that attacks the lining of the lungs and chest cavity. Karmanos is enrolling patients in a clinical trial that treats mesothelioma with Alimta® plus gemcitabine, an antimetabolite that may prevent tumor growth. Another clinical trial will look at a combination of Alimta®, surgery, and radiation to slow the spread of pleural mesothelioma tumors. Karmanos has established a hotline concerning asbestos, vermiculite, mesothelioma, asbestosis, and other asbestos diseases at 888-527-6266. The Institute is one of several medical centers treating asbestos diseases. The ASDTR's list of Occupational and Environmental Medical Clinics is also a useful resource.

Karmanos Cancer Hospital ZoomInfo Information

Industries

Key Personnel

• Ann Schwartz - President and Chief Executive Officer
• Mary Ann Short - Vice President, Marketing and Communications

Work for Karmanos Cancer Hospital and want to make adjustments to this page? Contact us to be given access to our management tools.